Jim Tananbaum
@JTananbaum
Followers
1K
Following
192
Media
1
Statuses
607
Founder and CEO of @foresitecapital, healthcare venture capital firm.
San Francisco, CA
Joined November 2011
Thank you to @FierceBiotech for their coverage of our new fund, announced today. It's an exciting time to be a biotech investor, and we look forward to continuing our support of the entrepreneurs who are making a difference.
fiercebiotech.com
Foresite Capital CEO Jim Tananbaum, M.D., says we’re in “one of the best biotech investment environments” of his multidecade career—and has rounded up $900 million to put that belief to the test wi |...
1
0
10
A new cohort of #VCUniversity starts tomorrow through @VCForward, with this amazing group of scholarship recipients in the life sciences track who will be reshaping our industry in years to come. My firm @ForesiteCapital is proud to continue our support of this program.
#VCUniversity Cohort 13 kicks off tomorrow! 🎉 We’re proud to have awarded full scholarships to the course for 40 new and aspiring VCs. Get to know them. 👉
1
0
12
Great news for the team at XinThera with their acquisition by @GileadSciences announced today. @ForesiteCapital was the founding investor. Read my colleague's thoughts here:
foresitecapital.com
Today we are pleased to share the news that XinThera has been acquired by Gilead Sciences. XinThera was founded in 2021 by Stephen Kaldor, Qing Dong, and Gene Hung, all serial entrepreneurs we have...
2
1
13
I'm thrilled to have joined the @LACMA board to help foster appreciation for culture and creativity in Los Angeles and beyond. Read my thoughts here:
medium.com
I am honored and delighted to have recently joined the board of the Los Angeles County Museum of Art, one of the most important art museums…
1
0
9
Congratulations to the team at @evonetix on this new funding round! We were excited to lead this investment to accelerate the company's commercial strategy and make gene synthesis more accessible.
0
0
6
It was an honor to welcome attendees on Saturday at Yale's for Humanity Illuminated event at the Yerba Buena Center. So proud to partner with this team. The @Yale community is incredibly special, and it was an inspirational day.
0
1
6
Please join my firm @ForesiteCapital in supporting this valuable program by volunteering as a life sciences peer mentor. The deadline is Friday.
VC Investors: Do you have 3-4 hours free to support a stronger, more diverse and inclusive ecosystem? This is the last week to volunteer as a VC Mentor for Cohort 11 of the #VCUniversity Mentorship Program! Learn more + sign up by this Friday, Sept. 30: https://t.co/oinzZrf1WR
1
0
0
Congratulations to the scholarship recipients of Cohort 11 for the @VCForward life sciences track of #VCUniversity! We are so proud of our work with this program. These people are the future of the life science VC industry, and I can't wait to see what they accomplish.
Introducing #VCUniversity ONLINE’s Cohort 11 Scholarship Recipients! Get to know these future leaders of the industry: https://t.co/4pOSTFNHy7
0
0
2
I'm proud to work with this team. Read our latest blog post from managing director Michael Rome.
Our managing director Michael Rome shares his thoughts on the @Affinivax acquisition by @GSK in our latest blog post:
0
0
6
Our managing director Michael Rome shares his thoughts on the @Affinivax acquisition by @GSK in our latest blog post:
foresitecapital.com
We were very excited today when GSK announced their acquisition of our portfolio company Affinivax. This is a great move to advance their vaccines that combat novel and resistant infectious diseases...
0
3
4
I'm proud to be supporting healthcare visionaries like Aaron.
3
1
14
I'm excited to support the team at @ElemBio as they unveil their benchtop sequencer AVITI. I believe sequencing will touch all our lives. To enable it, we need high quality, inexpensive sequencing.
Hear @JTananbaum Element board member & Founder/CEO of @ForesiteCapital describe how AVITI enables a major shift in the sequencing market. Register for our 3/14 virtual launch event to learn more: https://t.co/A08OUbd36s
#AviditySequencing #AVITI #NGS #Biotech #venturecapital
0
6
10
This is a stellar group, and I'm proud that my firm is providing full scholarships to the life sciences track for these future leaders in our industry. Thank you to @VCForward and the @nvca.
Introducing #VCUniversity ONLINE’s Cohort 9 Scholarship Recipients! Get to know these future leaders of the industry: https://t.co/p9ZauYHYJh
0
1
4
Congratulations to the newest @ForesiteLabs incubated company, @tensixteenbio , for launching today! The company is the first to leverage CHIP to uncover the mysterious mutations in the blood and how they impact disease. Read more via @endpts here:
endpoints.news
Mark Chao is going back into biotech — and his new company, launched this morning, is going after mysterious mutations in the blood and how they impact disease. If the name ...
0
2
13
Welcoming ImmPACT Bio to our portfolio! Early clinical data is very promising in our view. We believe the efficacy & safety profile of the lead program will help expand access of CAR-T cell therapy to patients who have exhausted other options. Excited to work with this team!
ImmPACT Bio unveiled a $111 million Series B round early Thursday morning, along with a C-suite shakeup and a first glimpse at some Phase I data. https://t.co/iwqg98NqBg
1
0
3
I'm very excited to announce the Tananbaum Center for Theoretical and Analytical Human Biology at @Yale led by @RMedzhitov to uncover fundamental knowledge about disease. Read about our new center here:
18
41
321
Great news out of @EikonTX yesterday, closing this round to help fuel their plans to analyze single molecule protein behavior in living cells. Their innovative tools and technologies for biological exploration will be used for drug discovery and beyond.
"How can you understand life if you don't look at it live?" — Eikon Therapeutics rakes in $518M https://t.co/oM9VNXheND by @emmakbetuel
0
0
3
Proud to be working with Pardes Biosciences -- with FSII we are working to combat COVID-19 via an oral medicine that, if approved by regulatory authorities, could be used to treat and prevent the disease. https://t.co/4opzXJXwaC
https://t.co/SvIc0zALYE
0
0
0
Thank you @amyfeldman for this thoughtful coverage of our portfolio company @TassoInc, bringing blood testing into the home to improve access to care.
What if you could draw blood at home rather than having it done at the doctor’s office? That’s the premise of Seattle-based startup Tasso
0
0
1
Really excited about this new initiative. Please help us spread the word to qualified applicants.
Thrilled to introduce our new program – Foresite Fellows! This is a twelve-week part-time paid internship program, 8-10 hours/wk remotely for those enrolled in PhD, MD, MD/MBA, MD/PhD, or postdoc programs. Learn more and apply here: https://t.co/rM5P8yoxPB
0
0
6